According to an announcement noting that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited bear no responsibility for its content, CK Life Sciences Int’l., (Holdings) Inc. (the “Company”) will hold a Board meeting on Tuesday, 17th March, 2026, in Hong Kong. The agenda includes approving the release of annual results for the financial year ended 31st December, 2025, and considering the payment of a final dividend. The announcement is dated 5th March, 2026.

As of the date of the announcement, the Executive Directors of the Company include Mr. Li Tzar Kuoi, Victor (Chairman), Mr. Kam Hing Lam, Mr. Ip Tak Chuen, Edmond, Mr. Yu Ying Choi, Alan Abel, Mr. Lance Richard Lee Yuen, and Dr. Toh Kean Meng, Melvin. The Non-executive Directors are Mr. Peter Peace Tulloch, Mrs. Kwok Eva Lee (Independent Non-executive Director), Mr. Kwan Kai Cheong (Independent Non-executive Director), Mr. Paul Joseph Tighe (Independent Non-executive Director), and Mr. Donald Jeffrey Roberts (Independent Non-executive Director).